Coffee could reverse chronic inflammation in aging people

Coffee drinkers tend to live longer than those who abstain from the caffeinated beverage, and new research from Stanford may help explain why and how it reduces chronic inflammation and cardiovascular disease.

The research, which included more than 100 participants, has revealed a connection between aging, systemic inflammation, cardiovascular disease and coffee consumption.

Prior research shows that inflammation can cause many cancers, Alzheimer’s disease, cardiovascular disease, osteoarthritis and even depression.

The investigators examined blood samples, survey data and medical and family histories from participants and published their work Jan. 16 in Nature Medicine.

They found that a fundamental inflammatory mechanism associated with aging that can cause cardiovascular disease could be countered by nucleic-acid metabolites in coffee.

“More than 90 percent of all noncommunicable diseases of aging are associated with chronic inflammation,” said David Furman, PhD, the study’s lead author and a consulting associate professor at the Stanford Institute for Immunity, Transplantation and Infection, in a statement. “It’s also well-known that caffeine intake is associated with longevity. Many studies have shown this association. We’ve found a possible reason for why this may be so.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.